D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
INFI holding history
Infinity Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
INFI overviewAll 13F holders of INFIFull Q2 2026 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −36,133−100.0% | Sold out | Holders |
| Q3 2022 | 36,133 | $43.0K | <0.1% | −759,054−95.5% | Reduced | Holders |
| Q2 2022 | 795,187 | $502.0K | <0.1% | −325,176−29.0% | Reduced | Holders |
| Q1 2022 | 1,120,363 | $1.28M | <0.1% | −464,097−29.3% | Reduced | Holders |
| Q4 2021 | 1,584,460 | $3.56M | <0.1% | −643,074−28.9% | Reduced | Holders |
| Q3 2021 | 2,227,534 | $7.62M | <0.1% | +2,119,509+1,962.1% | Added | Holders |
| Q2 2021 | 108,025 | $323.0K | <0.1% | +108,025 | New | Holders |